調査レポート | • レポートコード：QYR2104Z5027 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、咽頭後膿瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、鎮痛剤、手術的排膿法、その他）、用途別市場規模（病院・診療所、研究・学術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・咽頭後膿瘍の市場動向 ・企業の競争状況、市場シェア ・咽頭後膿瘍の種類別市場規模（抗生物質、鎮痛剤、手術的排膿法、その他） ・咽頭後膿瘍の用途別市場規模（病院・診療所、研究・学術、その他） ・咽頭後膿瘍の北米市場規模2016-2027（アメリカ、カナダ） ・咽頭後膿瘍のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・咽頭後膿瘍のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・咽頭後膿瘍の中南米市場規模2016-2027（メキシコ、ブラジル） ・咽頭後膿瘍の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck KGaA、Johnson & Johnson、AstraZeneca plc.、Sanofi S.A.、Pfizer、Mylan N.V.、Novartis AG、Teva pharmaceutical company、GlaxoSmithKline plc.） ・結論 |
A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.
Market Analysis and Insights: Global Retropharyngeal Abscess Market
The global Retropharyngeal Abscess market size is projected to reach US$ 5353 million by 2026, from US$ 4478.4 million in 2019, at a CAGR of 2.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retropharyngeal Abscess market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retropharyngeal Abscess market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retropharyngeal Abscess market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retropharyngeal Abscess market.
Global Retropharyngeal Abscess Scope and Market Size
Retropharyngeal Abscess market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retropharyngeal Abscess market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Pain Killers
Surgical Drainage
Others
Segment by Application
Hospitals and Clinics
Research and Academics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck KGaA
Johnson & Johnson
AstraZeneca plc.
Sanofi S.A.
Pfizer
Mylan N.V.
Novartis AG
Teva pharmaceutical company
GlaxoSmithKline plc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retropharyngeal Abscess Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Pain Killers
1.2.4 Surgical Drainage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Retropharyngeal Abscess Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Research and Academics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retropharyngeal Abscess Market Perspective (2016-2027)
2.2 Retropharyngeal Abscess Growth Trends by Regions
2.2.1 Retropharyngeal Abscess Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retropharyngeal Abscess Historic Market Share by Regions (2016-2021)
2.2.3 Retropharyngeal Abscess Forecasted Market Size by Regions (2022-2027)
2.3 Retropharyngeal Abscess Industry Dynamic
2.3.1 Retropharyngeal Abscess Market Trends
2.3.2 Retropharyngeal Abscess Market Drivers
2.3.3 Retropharyngeal Abscess Market Challenges
2.3.4 Retropharyngeal Abscess Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retropharyngeal Abscess Players by Revenue
3.1.1 Global Top Retropharyngeal Abscess Players by Revenue (2016-2021)
3.1.2 Global Retropharyngeal Abscess Revenue Market Share by Players (2016-2021)
3.2 Global Retropharyngeal Abscess Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retropharyngeal Abscess Revenue
3.4 Global Retropharyngeal Abscess Market Concentration Ratio
3.4.1 Global Retropharyngeal Abscess Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retropharyngeal Abscess Revenue in 2020
3.5 Retropharyngeal Abscess Key Players Head office and Area Served
3.6 Key Players Retropharyngeal Abscess Product Solution and Service
3.7 Date of Enter into Retropharyngeal Abscess Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retropharyngeal Abscess Breakdown Data by Type
4.1 Global Retropharyngeal Abscess Historic Market Size by Type (2016-2021)
4.2 Global Retropharyngeal Abscess Forecasted Market Size by Type (2022-2027)
5 Retropharyngeal Abscess Breakdown Data by Application
5.1 Global Retropharyngeal Abscess Historic Market Size by Application (2016-2021)
5.2 Global Retropharyngeal Abscess Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retropharyngeal Abscess Market Size (2016-2027)
6.2 North America Retropharyngeal Abscess Market Size by Type
6.2.1 North America Retropharyngeal Abscess Market Size by Type (2016-2021)
6.2.2 North America Retropharyngeal Abscess Market Size by Type (2022-2027)
6.2.3 North America Retropharyngeal Abscess Market Size by Type (2016-2027)
6.3 North America Retropharyngeal Abscess Market Size by Application
6.3.1 North America Retropharyngeal Abscess Market Size by Application (2016-2021)
6.3.2 North America Retropharyngeal Abscess Market Size by Application (2022-2027)
6.3.3 North America Retropharyngeal Abscess Market Size by Application (2016-2027)
6.4 North America Retropharyngeal Abscess Market Size by Country
6.4.1 North America Retropharyngeal Abscess Market Size by Country (2016-2021)
6.4.2 North America Retropharyngeal Abscess Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Retropharyngeal Abscess Market Size (2016-2027)
7.2 Europe Retropharyngeal Abscess Market Size by Type
7.2.1 Europe Retropharyngeal Abscess Market Size by Type (2016-2021)
7.2.2 Europe Retropharyngeal Abscess Market Size by Type (2022-2027)
7.2.3 Europe Retropharyngeal Abscess Market Size by Type (2016-2027)
7.3 Europe Retropharyngeal Abscess Market Size by Application
7.3.1 Europe Retropharyngeal Abscess Market Size by Application (2016-2021)
7.3.2 Europe Retropharyngeal Abscess Market Size by Application (2022-2027)
7.3.3 Europe Retropharyngeal Abscess Market Size by Application (2016-2027)
7.4 Europe Retropharyngeal Abscess Market Size by Country
7.4.1 Europe Retropharyngeal Abscess Market Size by Country (2016-2021)
7.4.2 Europe Retropharyngeal Abscess Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retropharyngeal Abscess Market Size (2016-2027)
8.2 Asia-Pacific Retropharyngeal Abscess Market Size by Type
8.2.1 Asia-Pacific Retropharyngeal Abscess Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retropharyngeal Abscess Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retropharyngeal Abscess Market Size by Type (2016-2027)
8.3 Asia-Pacific Retropharyngeal Abscess Market Size by Application
8.3.1 Asia-Pacific Retropharyngeal Abscess Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retropharyngeal Abscess Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retropharyngeal Abscess Market Size by Application (2016-2027)
8.4 Asia-Pacific Retropharyngeal Abscess Market Size by Region
8.4.1 Asia-Pacific Retropharyngeal Abscess Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retropharyngeal Abscess Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retropharyngeal Abscess Market Size (2016-2027)
9.2 Latin America Retropharyngeal Abscess Market Size by Type
9.2.1 Latin America Retropharyngeal Abscess Market Size by Type (2016-2021)
9.2.2 Latin America Retropharyngeal Abscess Market Size by Type (2022-2027)
9.2.3 Latin America Retropharyngeal Abscess Market Size by Type (2016-2027)
9.3 Latin America Retropharyngeal Abscess Market Size by Application
9.3.1 Latin America Retropharyngeal Abscess Market Size by Application (2016-2021)
9.3.2 Latin America Retropharyngeal Abscess Market Size by Application (2022-2027)
9.3.3 Latin America Retropharyngeal Abscess Market Size by Application (2016-2027)
9.4 Latin America Retropharyngeal Abscess Market Size by Country
9.4.1 Latin America Retropharyngeal Abscess Market Size by Country (2016-2021)
9.4.2 Latin America Retropharyngeal Abscess Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retropharyngeal Abscess Market Size (2016-2027)
10.2 Middle East & Africa Retropharyngeal Abscess Market Size by Type
10.2.1 Middle East & Africa Retropharyngeal Abscess Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retropharyngeal Abscess Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retropharyngeal Abscess Market Size by Type (2016-2027)
10.3 Middle East & Africa Retropharyngeal Abscess Market Size by Application
10.3.1 Middle East & Africa Retropharyngeal Abscess Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retropharyngeal Abscess Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retropharyngeal Abscess Market Size by Application (2016-2027)
10.4 Middle East & Africa Retropharyngeal Abscess Market Size by Country
10.4.1 Middle East & Africa Retropharyngeal Abscess Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retropharyngeal Abscess Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Retropharyngeal Abscess Introduction
11.1.4 Merck KGaA Revenue in Retropharyngeal Abscess Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Retropharyngeal Abscess Introduction
11.2.4 Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 AstraZeneca plc.
11.3.1 AstraZeneca plc. Company Details
11.3.2 AstraZeneca plc. Business Overview
11.3.3 AstraZeneca plc. Retropharyngeal Abscess Introduction
11.3.4 AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2016-2021)
11.3.5 AstraZeneca plc. Recent Development
11.4 Sanofi S.A.
11.4.1 Sanofi S.A. Company Details
11.4.2 Sanofi S.A. Business Overview
11.4.3 Sanofi S.A. Retropharyngeal Abscess Introduction
11.4.4 Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2016-2021)
11.4.5 Sanofi S.A. Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Retropharyngeal Abscess Introduction
11.5.4 Pfizer Revenue in Retropharyngeal Abscess Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Retropharyngeal Abscess Introduction
11.6.4 Mylan N.V. Revenue in Retropharyngeal Abscess Business (2016-2021)
11.6.5 Mylan N.V. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Retropharyngeal Abscess Introduction
11.7.4 Novartis AG Revenue in Retropharyngeal Abscess Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Teva pharmaceutical company
11.8.1 Teva pharmaceutical company Company Details
11.8.2 Teva pharmaceutical company Business Overview
11.8.3 Teva pharmaceutical company Retropharyngeal Abscess Introduction
11.8.4 Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2016-2021)
11.8.5 Teva pharmaceutical company Recent Development
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Company Details
11.9.2 GlaxoSmithKline plc. Business Overview
11.9.3 GlaxoSmithKline plc. Retropharyngeal Abscess Introduction
11.9.4 GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2016-2021)
11.9.5 GlaxoSmithKline plc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retropharyngeal Abscess Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Pain Killers
Table 4. Key Players of Surgical Drainage
Table 5. Key Players of Others
Table 6. Global Retropharyngeal Abscess Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Retropharyngeal Abscess Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retropharyngeal Abscess Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Retropharyngeal Abscess Market Share by Regions (2016-2021)
Table 10. Global Retropharyngeal Abscess Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Retropharyngeal Abscess Market Share by Regions (2022-2027)
Table 12. Retropharyngeal Abscess Market Trends
Table 13. Retropharyngeal Abscess Market Drivers
Table 14. Retropharyngeal Abscess Market Challenges
Table 15. Retropharyngeal Abscess Market Restraints
Table 16. Global Retropharyngeal Abscess Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Retropharyngeal Abscess Market Share by Players (2016-2021)
Table 18. Global Top Retropharyngeal Abscess Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess as of 2020)
Table 19. Ranking of Global Top Retropharyngeal Abscess Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Retropharyngeal Abscess Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retropharyngeal Abscess Product Solution and Service
Table 23. Date of Enter into Retropharyngeal Abscess Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Retropharyngeal Abscess Revenue Market Share by Type (2016-2021)
Table 27. Global Retropharyngeal Abscess Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Retropharyngeal Abscess Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Retropharyngeal Abscess Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Retropharyngeal Abscess Revenue Market Share by Application (2016-2021)
Table 31. Global Retropharyngeal Abscess Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Retropharyngeal Abscess Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Retropharyngeal Abscess Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Retropharyngeal Abscess Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Retropharyngeal Abscess Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Retropharyngeal Abscess Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Retropharyngeal Abscess Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Retropharyngeal Abscess Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Retropharyngeal Abscess Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Retropharyngeal Abscess Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Retropharyngeal Abscess Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Retropharyngeal Abscess Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retropharyngeal Abscess Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retropharyngeal Abscess Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retropharyngeal Abscess Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retropharyngeal Abscess Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Retropharyngeal Abscess Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Retropharyngeal Abscess Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Retropharyngeal Abscess Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Retropharyngeal Abscess Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Retropharyngeal Abscess Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Retropharyngeal Abscess Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retropharyngeal Abscess Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retropharyngeal Abscess Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retropharyngeal Abscess Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retropharyngeal Abscess Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retropharyngeal Abscess Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Retropharyngeal Abscess Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Retropharyngeal Abscess Product
Table 66. Merck KGaA Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Retropharyngeal Abscess Product
Table 71. Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. AstraZeneca plc. Company Details
Table 74. AstraZeneca plc. Business Overview
Table 75. AstraZeneca plc. Retropharyngeal Abscess Product
Table 76. AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca plc. Recent Development
Table 78. Sanofi S.A. Company Details
Table 79. Sanofi S.A. Business Overview
Table 80. Sanofi S.A. Retropharyngeal Abscess Product
Table 81. Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 82. Sanofi S.A. Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Retropharyngeal Abscess Product
Table 86. Pfizer Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Mylan N.V. Company Details
Table 89. Mylan N.V. Business Overview
Table 90. Mylan N.V. Retropharyngeal Abscess Product
Table 91. Mylan N.V. Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 92. Mylan N.V. Recent Development
Table 93. Novartis AG Company Details
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Retropharyngeal Abscess Product
Table 96. Novartis AG Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 97. Novartis AG Recent Development
Table 98. Teva pharmaceutical company Company Details
Table 99. Teva pharmaceutical company Business Overview
Table 100. Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 101. Teva pharmaceutical company Recent Development
Table 102. GlaxoSmithKline plc. Company Details
Table 103. GlaxoSmithKline plc. Business Overview
Table 104. GlaxoSmithKline plc. Retropharyngeal Abscess Product
Table 105. GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2016-2021) & (US$ Million)
Table 106. GlaxoSmithKline plc. Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retropharyngeal Abscess Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Pain Killers Features
Figure 4. Surgical Drainage Features
Figure 5. Others Features
Figure 6. Global Retropharyngeal Abscess Market Share by Application: 2020 VS 2027
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Research and Academics Case Studies
Figure 9. Others Case Studies
Figure 10. Retropharyngeal Abscess Report Years Considered
Figure 11. Global Retropharyngeal Abscess Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Retropharyngeal Abscess Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Retropharyngeal Abscess Market Share by Regions: 2020 VS 2027
Figure 14. Global Retropharyngeal Abscess Market Share by Regions (2022-2027)
Figure 15. Global Retropharyngeal Abscess Market Share by Players in 2020
Figure 16. Global Top Retropharyngeal Abscess Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Retropharyngeal Abscess Revenue in 2020
Figure 18. Global Retropharyngeal Abscess Revenue Market Share by Type (2016-2021)
Figure 19. Global Retropharyngeal Abscess Revenue Market Share by Type (2022-2027)
Figure 20. North America Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Retropharyngeal Abscess Market Share by Type (2016-2027)
Figure 22. North America Retropharyngeal Abscess Market Share by Application (2016-2027)
Figure 23. North America Retropharyngeal Abscess Market Share by Country (2016-2027)
Figure 24. United States Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retropharyngeal Abscess Market Share by Type (2016-2027)
Figure 28. Europe Retropharyngeal Abscess Market Share by Application (2016-2027)
Figure 29. Europe Retropharyngeal Abscess Market Share by Country (2016-2027)
Figure 30. Germany Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retropharyngeal Abscess Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Retropharyngeal Abscess Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Retropharyngeal Abscess Market Share by Region (2016-2027)
Figure 40. China Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retropharyngeal Abscess Market Share by Type (2016-2027)
Figure 48. Latin America Retropharyngeal Abscess Market Share by Application (2016-2027)
Figure 49. Latin America Retropharyngeal Abscess Market Share by Country (2016-2027)
Figure 50. Mexico Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retropharyngeal Abscess Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Retropharyngeal Abscess Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Retropharyngeal Abscess Market Share by Country (2016-2027)
Figure 56. Turkey Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Retropharyngeal Abscess Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck KGaA Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 61. AstraZeneca plc. Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 62. Sanofi S.A. Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 64. Mylan N.V. Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 66. Teva pharmaceutical company Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 67. GlaxoSmithKline plc. Revenue Growth Rate in Retropharyngeal Abscess Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の骨痛治療市場規模・現状・予測（2021年-2027年） Bone pain is an ache in one or more bones in the body. The pain is generally connected to diseases that influence the normal function or structure of the bone. The major factor that drives the market is the increasing ageing population. There are various causes for bone pain disease such as Injury, …- 世界のスポーツ表面排水システム市場規模・現状・予測（2021年-2027年） Sport Surface Drainage Systems maximize the functionality of the athletic facility without disrupting the performance of athletes and players. Market Analysis and Insights: Global Sport Surface Drainage Systems Market The global Sport Surface Drainage Systems market size is projected to reach US$ XX…
- 世界の慢性腰痛治療市場規模・現状・予測（2021年-2027年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…
- 世界の膝痛管理市場規模・現状・予測（2021年-2027年） Knee pain is a common pain associated with the bone structure of knee. Knee pain is often associated with age. Knee pain includes: limping due to discomfort, difficulty walking, climbing stairs, locking of knee, redness, swelling and inability to extend knee. The increasing cases of arthritis due to…
- 世界の内臓痛市場規模・現状・予測（2021年-2027年） Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutt…